Skip to main content

Table 3 Changes in risperidone doses

From: Prolactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia

Group Baseline 4 weeks 12 weeks 20 weeks 26 weeks 34 weeks 52 weeks
(mg/d) Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
4-week dose 4.4 0.8 4.2 0.8 2.2a 0.4 2.2 0.5 2.1 0.4 2.1 0.4 2.1 0.4
26-week dose 4.2 0.5 4.2 0.6 4.2 0.5 4.2 0.5 3.8 0.9 2.1b 0.3 2.0 0.3
Therapeutic dose 4.3 0.6 4.3 0.6 4.2 0.7 4.3 0.6 4.2 0.6 4.3 0.6 4.2 0.6
  1. aMean doses when the dose reduction was completed in the 4-week group
  2. bMean doses when the dose reduction was completed in the 26-week group